The Recovery Peptide Reality Guide
BPC-157 and TB-500 are everywhere in the gym. Here’s the honest version of what the research shows, and how not to get sold garbage. Education, not medical advice.
1. Most of the evidence is in rats
The dramatic recovery claims for BPC-157 and TB-500 rest largely on animal studies. That doesn’t make them worthless, it makes them unproven in humans. Treat confident human promises with skepticism.
2. “Healed my injury” is an anecdote, not data
Recovery is noisy. People heal, rest, and improve for many reasons. A testimonial tells you what someone believes happened, not what the compound caused.
- Injuries often improve with time and rest alone.
- Stacking many things at once makes attribution impossible.
- Survivorship bias: you hear from the people who felt it worked.
3. Sourcing adds another risk
For lifters, uncertainty about identity, purity, sterility, and storage adds to the limited human evidence. We do not publish a universal product-failure percentage without a traceable dataset. An independently verifiable laboratory report tied to the exact lot is only a starting point, not proof of safety or effectiveness.
Sources for this guide
- FDA: bulk substances that may present significant safety risks (Regulatory source)
Reviewed August 24, 2026. Educational editorial content; no named clinician review is claimed.
We cut the bro-science weekly.
Mendwire reports what the research actually shows on recovery peptides, plus who’s legit. Free.
Subscribe free →Mendwire is independent education and news, not medical advice. Nothing here is a recommendation to buy, use, or dose any compound. Talk to a qualified clinician about your health.